Literature DB >> 25541433

Relationship of common vascular endothelial growth factor polymorphisms and haplotypes with the risk of cervical cancer in Tunisians.

Sabrina Zidi1, Mouna Stayoussef2, Ezzedine Gazouani3, Amel Mezlini4, Besma Yacoubi-Loueslati1, Wassim Y Almawi5.   

Abstract

OBJECTIVE: We investigated the association between common vascular endothelial growth factor (VEGF) single nucleotide polymorphisms (SNPs) and the risk of cervical cancer (CC) in Tunisian patients and control women.
METHODS: Study subjects comprised 86 CC cases and 124 control women. Genotyping of VEGF rs699947, rs833061, rs1570360, rs2010963, rs25648, rs833068, rs833070, rs3025039 SNPs was done by real-time PCR.
RESULTS: Higher minor allele frequencies (MAF) of rs699947 (-2578C/A) [P=0.04; OR (95% CI)=1.52 (1.02-2.29)], and rs1570360 (-1154G/A) [P=0.04; OR (95% CI)=1.58 (1.01-2.47)] were seen in CC cases compared to control women. Marked differences in the distribution of rs699947 (P=9×10(-4)) and rs1570360 (P=0.03) genotypes were seen between CC cases and control groups; the distribution of the remaining SNPs was comparable between CC cases and control women. The association of rs699947 and rs1570360 with heightened CC risk with was seen in the heterozygous, and more so in the homozygous states. Haploview analysis revealed high LD between rs699947, rs833061, rs1570360, rs2010963, rs25648, rs833068 and rs833070 but weak or no LD between rs3025039 and the other SNPs. Seven-locus (rs699947/rs833061/rs1570360/rs2010963/rs25648/rs833068/ rs833070) haploview analysis identified only CTGCCAG haplotype to be positively associated with CC [P=0.022; OR(95% CI)=1.74 (1.08-2.79)].
CONCLUSION: Specific VEGF variants (rs699947, rs1570360) and haplotype (CTGCCAG) may contribute to the development of CC among Tunisian women.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cervical cancer; Haplotypes; Polymorphisms; Tunisians; VEGF

Mesh:

Substances:

Year:  2014        PMID: 25541433     DOI: 10.1016/j.cyto.2014.11.009

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  7 in total

1.  Haplotype-based association of Vascular Endothelial Growth Factor gene polymorphisms with urothelial bladder cancer risk in Tunisian population.

Authors:  Safa Ben Wafi; Amani Kallel; Mohamed Kacem Ben Fradj; Ahmed Sallemi; Sami Ben Rhouma; Meriam Ben Halima; Haifa Sanhaji; Yassine Nouira; Riadh Jemaa; Moncef Feki
Journal:  J Clin Lab Anal       Date:  2018-06-29       Impact factor: 2.352

2.  Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma.

Authors:  İlknur Bingül; Pervin Vural; Semra Doğru-Abbasoğlu; Esra Çil; Müjdat Uysal
Journal:  J Clin Lab Anal       Date:  2016-12-07       Impact factor: 2.352

3.  Relationships between Common and Novel Interleukin-6 Gene Polymorphisms and Risk of Cervical Cancer: a Case-Control Study.

Authors:  Sabrina Zidi; Mouna Stayoussef; Bano L Alsaleh; Ezzedine Gazouani; Amel Mezlini; Bashayer H Ebrahim; Besma Yacoubi-Loueslati; Wassim Y Almawi
Journal:  Pathol Oncol Res       Date:  2016-10-08       Impact factor: 3.201

4.  Analysis of VEGFA Variants and Changes in VEGF Levels Underscores the Contribution of VEGF to Polycystic Ovary Syndrome.

Authors:  Wassim Y Almawi; Emily Gammoh; Zainab H Malalla; Safa A Al-Madhi
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

5.  Circulating vascular endothelial growth factor and cancer risk: A bidirectional mendelian randomization.

Authors:  Hong Wu; Tianjun Ma; Dongli Li; Mei He; Hui Wang; Ying Cui
Journal:  Front Genet       Date:  2022-09-07       Impact factor: 4.772

6.  Analysis of VEGF gene polymorphisms and serum VEGF protein levels contribution in polycystic ovary syndrome of patients.

Authors:  Lei Bao; Rabbani Syed; Mustafa Sawsan Aloahd
Journal:  Mol Biol Rep       Date:  2019-08-05       Impact factor: 2.316

7.  Transcriptome changes induced by RUNX3 in cervical cancer cells in vitro.

Authors:  Qian-Qian Gao; Bin Zhou; Xiu-Zhang Yu; Zhu Zhang; Yan-Yun Wang; Ya-Ping Song; Lin Zhang; Hong Luo; Ming-Rong Xi
Journal:  Oncol Lett       Date:  2019-11-21       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.